| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDTX | Stock Option (right to buy) | Award | $0 | +4.25K | $0.00 | 4.25K | Apr 26, 2024 | Common Stock | 4.25K | $12.63 | See Footnotes | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | 1/3rd of the total number of shares subject to the award shall vest on April 26, 2025 and the remaining 2/3rds of the shares will vest in equal monthly installments over a two year period such that the option is fully vested on April 26, 2027. |
| F2 | RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein. |
| F3 | Laura Tadvalkar is a Managing Director of the Adviser who serves on the Issuer's board of directors. Under Dr. Tadvalkar's arrangement with the Adviser, Dr. Tadvalkar holds the option for the benefit of the Fund. Dr. Tadvalkar is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock. |
Dr. Laura Tadvalkar, a Managing Director of the Adviser, serves on the Issuer's board of directors.